MedTrace Logo

Intestinal Microbiome and Chronic Inflammatory Bowel Disease

NCT02768038 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-05-01

No results posted yet for this study

Summary

The aim is to examine the role of intestinal microbiota in the pathogenesis of chronic inflammatory bowel diseases (IBD)

Conditions

Interventions

OTHER

Observational

Blood, stool ja biopsy specimens

Sponsors & Collaborators

  • Turku University Hospital

    lead OTHER_GOV

Principal Investigators

  • Markku Voutilainen, Prof. · Head, Department of Gastroenterology

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-01
Primary Completion
2020-12-01
Completion
2020-12-01

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02768038 on ClinicalTrials.gov